Refereed journal article or data article (A1)
The CJEU broadens the scope of European SPCs, but shortens validity of its duration in certain Member States
List of Authors: Daniel Acquah
Publisher: Oxford University Press
Place: Oxford
Publication year: 2017
Journal: Journal of Intellectual Property Law and Practice
Journal acronym: JIPLP
Volume number: 12
Issue number: 4
Number of pages: 2
ISSN: 1747-1532
eISSN: 1747-1540
DOI: http://dx.doi.org/10.1093/jiplp/jpx016
URL: https://academic.oup.com/jiplp/article/12/4/263/3065362/The-CJEU-broadens-the-scope-of-European-SPCs-but
Self-archived copy’s web address: https://research.utu.fi/converis/portal/detail/Publication/19260413
The Court of Justice of the European Union (CJEU) has clarified that, where a medicinal product has been the subject of a marketing authorization (MA) within the European Economic Area (EEA), before that granted in a Member State of the European Union (EU), and even before the Member State’s accession to the EU, the EEA MA must be taken into account for the purpose of determining the duration of the supplementary protection certificate granted in the EU.
Downloadable publication This is an electronic reprint of the original article. |  |
